Mining the Melanosome for Tumor Vaccine Targets: P.polypeptide Is a Novel Tumor-associated Antigen

Por Touloukian, Christopher E., Leitner, Wolfgang W., Robbins, Paul F., Rosenberg, Steven A., Restifo, Nicholas P.
Publicado em 2001

Identification of CD4(+) T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules

Por Zeng, Gang, Touloukian, Christopher E., Wang, Xiang, Restifo, Nicholas P., Rosenberg, Steven A., Wang, Rong-Fu
Publicado em 2000

High avidity autoreactive CD4(+) T cells induce host CTL, overcome T(regs) and mediate tumor destruction

Por Brandmaier, Andrew G., Leitner, Wolfgang W., Ha, Sung P., Sidney, John, Restifo, Nicholas P., Touloukian, Christopher E.
Publicado em 2009

MHC class I and class II Presentation of Tumor Antigen in Retrovirally and Adenovirally Transduced Dendritic Cells

Por Sloan, J Mark, Kershaw, Michael H, Touloukian, Christopher E, Lapointe, Rejean, Robbins, Paul F, Restifo, Nicholas P, Hwu, Patrick
Publicado em 2002

Assumptions of the tumor ‘escape’ hypothesis

Por Restifo, Nicholas P., Antony, Paul A., Finkelstein, Steven E., Leitner, Wolfgang W., Surman, Deborah R., Theoret, Marc R., Touloukian, Christopher E.
Publicado em 2002

Identification of a MHC Class II-Restricted Human gp100 Epitope Using DR4-IE Transgenic Mice

Por Touloukian, Christopher E., Leitner, Wolfgang W., Topalian, Suzanne L., Li, Yong F., Robbins, Paul F., Rosenberg, Steven A., Restifo, Nicholas P.
Publicado em 2000

Normal Tissue Depresses While Tumor Tissue Enhances Human T Cell Responses In Vivo to a Novel Self/Tumor Melanoma Antigen, OA1

Por Touloukian, Christopher E., Leitner, Wolfgang W., Schnur, Rhonda E., Robbins, Paul F., Li, Yong, Southwood, Scott, Sette, Alessandro, Rosenberg, Steven A., Restifo, Nicholas P.
Publicado em 2003

Expression of a “Self-” Antigen by Human Tumor Cells Enhances Tumor Antigen-specific CD4(+) T-Cell Function

Por Touloukian, Christopher E., Leitner, Wolfgang W., Robbins, Paul F., Li, Yong F., Kang, Xiaoqiang, Lapointe, Rejean, Hwu, Patrick, Rosenberg, Steven A., Restifo, Nicholas P.
Publicado em 2002

Poor immunogenicity of a self/tumor antigen derives from peptide–MHC-I instability and is independent of tolerance

Por Yu, Zhiya, Theoret, Marc R., Touloukian, Christopher E., Surman, Deborah R., Garman, Scott C., Feigenbaum, Lionel, Baxter, Tiffany K., Baker, Brian M., Restifo, Nicholas P.
Publicado em 2004

Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4(+) T lymphocytes

Por Overwijk, Willem W., Lee, David S., Surman, Deborah R., Irvine, Kari R., Touloukian, Christopher E., Chan, Chi-Chao, Carroll, Miles W., Moss, Bernard, Rosenberg, Steven A., Restifo, Nicholas P.
Publicado em 1999

Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity

Por Ha, Sung P., Klemen, Nicholas D., Kinnebrew, Garrett H., Brandmaier, Andrew G., Marsh, Jon, Hangoc, Giao, Palmer, Douglas C., Restifo, Nicholas P., Cornetta, Kenneth, Broxmeyer, Hal E., Touloukian, Christopher E.
Publicado em 2010

The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists

Por Sahu, Ravi P., Turner, Matthew J., DaSilva, Sonia C., Rashid, Badri M., Ocana, Jesus A., Perkins, Susan M., Konger, Raymond L., Touloukian, Christopher E., Kaplan, Mark H., Travers, Jeffrey B.
Publicado em 2012

Recombinant Virus Vaccination against “Self” Antigens Using Anchor-fixed Immunogens

Por Irvine, Kari R., Parkhurst, Maria R., Shulman, Eliza P., Tupesis, Janis P., Custer, Mary, Touloukian, Christopher E., Robbins, Paul F., Yafal, Alicia Gómez, Greenhalgh, Patricia, Sutmuller, Roger P. M., Offringa, Rienk, Rosenberg, Steven A., Restifo, Nicholas P.
Publicado em 1999

Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class Ii-Restricted Peptides from Melanoma-Associated Antigens

Por Phan, Giao Q., Touloukian, Christopher E., Yang, James C., Restifo, Nicholas P., Sherry, Richard M., Hwu, Patrick, Topalian, Suzanne L., Schwartzentruber, Douglas J., Seipp, Claudia A., Freezer, Linda J., Morton, Kathleen E., Mavroukakis, Sharon A., White, Donald E., Rosenberg, Steven A.
Publicado em 2003

Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor

Por Sahu, Ravi P., Ocana, Jesus A., Harrison, Kathleen A., Ferracini, Matheus, Touloukian, Christopher E., Al-Hassani, Mohammed, Sun, Louis, Loesch, Mathew, Murphy, Robert C., Althouse, Sandra K., Perkins, Susan M., Speicher, Paul J., Tyler, Douglas S., Konger, Raymond L., Travers, Jeffrey B.
Publicado no Cancer Res (2014)

Tumor-specific Th17-polarized cells eradicate large established melanoma

Por Muranski, Pawel, Boni, Andrea, Antony, Paul A., Cassard, Lydie, Irvine, Kari R., Kaiser, Andrew, Paulos, Chrystal M., Palmer, Douglas C., Touloukian, Christopher E., Ptak, Krzysztof, Gattinoni, Luca, Wrzesinski, Claudia, Hinrichs, Christian S., Kerstann, Keith W., Feigenbaum, Lionel, Chan, Chi-Chao, Restifo, Nicholas P.
Publicado em 2008